A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study

Carol Aghajanian^*, John A. Blessing, Kathleen M. Darcy, Gary Reid, Koen DeGeest, Stephen C. Rubin, Robert S. Mannel, Jacob Rotmensch, Russell J. Schilder, William Riordan

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review